Document:

Exhibit 4.3

 

THIS WARRANT HAS NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES
LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION
STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE,
REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT
REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL
AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF
THIS WARRANT.

 

RIGHTNOW TECHNOLOGIES, INC.

 

WARRANT TO PURCHASE [NUMBER OF SHARES] SHARES

OF SERIES B PREFERRED STOCK

 

THIS CERTIFIES
THAT, for value received, [NAME OF WARRANT HOLDER] and its assignees are
entitled to subscribe for and purchase [NUMBER OF SHARES] shares of the fully
paid and non assessable Series B Preferred Stock (as adjusted pursuant to
Section 4 hereof, the “Shares”) of RIGHTNOW TECHNOLOGIES, INC., a Delaware
corporation (the “Company”), at the price of $3.00 per share (such price and
such other price as shall result, from time to time, from the adjustments
specified in Section 4 hereof is herein referred to as the “Warrant
Price”), subject to the provisions and upon the terms and conditions
hereinafter set forth. As used herein, (a) the term “Series Preferred” shall
mean the Company’s presently authorized Series B Preferred Stock, and any stock
into or for which such Series B Preferred Stock may hereafter be converted or
exchanged, and after the automatic conversion of the Series B Preferred Stock to
Common Stock shall mean the Company’s Common Stock, (b) the term “Date of
Grant” shall mean [DATE OF GRANT], and (c) the term “Other Warrants” shall mean
any other warrants issued by the Company in connection with the transaction
with respect to which this Warrant was issued, and any warrant issued upon
transfer or partial exercise of or in lieu of this Warrant. The term “Warrant”
as used herein shall be deemed to include Other Warrants unless the context
clearly requires otherwise.

 

1.             Term.  The purchase right represented by this
Warrant is exercisable, in whole or in part, at any time and from time to time
from the Date of Grant through the later of (i) ten (10) years after the Date
of Grant or (ii) five (5) years after the closing of the Company’s initial
public offering of its Common Stock (“IPO”) effected pursuant to a Registration
Statement filed under the Securities Act of 1933, as amended (the “Act”).

 

2.             Method of
Exercise; Payment; Issuance of New Warrant. 
Subject to Section 1 hereof, the purchase right represented by
this Warrant may be exercised by the holder hereof, in whole or in part and
from time to time, at the election of the holder hereof, by (a) the surrender
of this Warrant (with the notice of exercise substantially in the form attached
hereto as Exhibit A-1 duly completed and executed) at the principal
office of the Company and by the payment to the Company, by certified or bank
check, or by wire transfer to an account designated by the Company (a “Wire
Transfer”) of an

 

 

amount equal to the then
applicable Warrant Price multiplied by the number of Shares then being
purchased; (b) if in connection with a registered public offering of the
Company’s securities, the surrender of this Warrant (with the notice of
exercise form attached hereto as Exhibit A-2 duly completed and executed) at
the principal office of the Company together with notice of arrangements
reasonably satisfactory to the Company for payment to the Company either by
certified or bank check or by Wire Transfer from the proceeds of the sale of
shares to be sold by the holder in such public offering of an amount equal to
the then applicable Warrant Price per share multiplied by the number of Shares
then being purchased; or (c) exercise of the “net issuance” right provided for
in Section 10.2 hereof. The person or persons in whose name(s) any
certificate(s) representing shares of Series Preferred shall be issuable upon
exercise of this Warrant shall be deemed to have become the holder(s) of record
of, and shall be treated for all purposes as the record holder(s) of, the
shares represented thereby (and such
shares shall be deemed to have been issued) immediately prior to the close of
business on the date or dates upon which this Warrant is exercised. In
the event of any exercise of the rights represented by this Warrant,
certificates for the shares of stock so purchased shall be delivered to the
holder hereof as soon as possible and in any event within thirty (30) days
after such exercise and, unless this Warrant has been fully exercised or
expired, a new Warrant representing the portion of the Shares, if any, with
respect to which this Warrant shall not then have been exercised shall also be
issued to the holder hereof as soon as possible and in any event within such
thirty-day period; provided, however, at such time as the Company is subject to
the reporting requirements of the Securities Exchange Act of 1934, as amended,
if requested by the holder of this Warrant, the Company shall cause its
transfer agent to deliver the certificate representing Shares issued upon
exercise of this Warrant to a broker or other person (as directed by the holder
exercising this Warrant) within the time period required to settle any trade
made by the holder after exercise of this Warrant.

 

3.             Stock Fully Paid;
Reservation of Shares.  All Shares
that may be issued upon the exercise of the rights represented by this Warrant
will, upon issuance pursuant to the terms and conditions herein, be fully paid and nonassessable, and free from all taxes,
liens and charges with respect to the issue thereof. During the period within
which the rights represented by this Warrant may be exercised, the Company will
at all times have authorized, and reserved for the purpose of the issue upon
exercise of the purchase rights evidenced by this Warrant, a sufficient number
of shares of its Series Preferred to provide for the exercise of the rights
represented by this Warrant and a sufficient number of shares of its Common
Stock to provide for the conversion of the Series Preferred into Common Stock.

 

4.             Adjustment of
Warrant Price and Number of Shares. The number and kind of securities
purchasable upon the exercise of this Warrant and the Warrant Price shall be
subject to adjustment from time to time upon the occurrence of certain events,
as follows:

 

(a)           Reclassification or
Merger. In case of any reclassification or change of securities of the
class issuable upon exercise of this Warrant (other than a change in par value,
or from par value to no par value, or from no par value to par value, or as a 

 

 

result of a subdivision or
combination), or in case of any merger of the Company with or into another
corporation (other than a merger with another corporation in which the Company
is the acquiring and the surviving corporation and which does not result in any
reclassification or change of outstanding securities issuable upon exercise of
this Warrant), or in case of any sale of all or substantially all of the assets
of the Company, the Company, or such successor or purchasing corporation, as
the case may be, shall duly execute and deliver to the holder of this Warrant a
new Warrant (in form and substance satisfactory to the holder of this Warrant),
or the Company shall make appropriate provision without the issuance of a new Warrant,
so that the holder of this Warrant shall have the right to receive, at a total
purchase price not to exceed that payable upon the exercise of the unexercised
portion of this Warrant, and in lieu of the shares of Series Preferred
theretofore issuable upon exercise of this Warrant, (i) the kind and amount of
shares of stock, other securities, money and property receivable upon such
reclassification, change, merger or sale by a holder of the number of shares of
Series Preferred then purchasable under this Warrant, or (ii) in the case of
such a merger or sale in which the consideration paid consists all or in part
of assets other than securities of the successor or purchasing corporation, at
the option of the Holder of this Warrant, the securities of the successor or
purchasing corporation having a value at the time of the transaction equivalent
to the valuation of the Series Preferred at the time of the transaction. Any
new Warrant shall provide for adjustments that shall be as nearly equivalent as
may be practicable to the adjustments provided for in this Section 4. The
provisions of this subparagraph (a) shall similarly apply to successive
reclassifications, changes, mergers and transfers.

 

(b)           Subdivision or
Combination of Shares. If the Company at any time while this Warrant
remains outstanding and unexpired shall subdivide or combine its outstanding
shares of Series Preferred, the Warrant Price shall be proportionately
decreased and the number of Shares issuable hereunder shall be proportionately
increased in the case of a subdivision and the Warrant Price shall be
proportionately increased and the number of Shares issuable hereunder shall be
proportionately decreased in the case of a combination.

 

(c)           Stock Dividends and
Other Distributions. If the Company at any time while this Warrant is
outstanding and unexpired shall (i) pay a dividend with respect to Series
Preferred payable in Series Preferred, then the Warrant Price shall be
adjusted, from and after the date of determination of shareholders entitled to
receive such dividend or distribution, to that price determined by multiplying
the Warrant Price in effect immediately prior to such date of determination by
a fraction (A) the numerator of which shall be the total number of shares of
Series Preferred outstanding immediately prior to such dividend or
distribution, and (B) the denominator of which shall be the total number of
shares of Series Preferred outstanding immediately after such dividend or
distribution; or (ii) make any other distribution with respect to Series
Preferred (except any distribution specifically provided for in Sections
4(a) and 4(b)), then, in each such case, provision shall be made by the
Company such that the holder of this Warrant shall receive upon exercise of
this Warrant a proportionate share of any such dividend or distribution as
though it were the holder of the Series Preferred (or Common Stock

 

 

issuable
upon conversion thereof) as of the record date fixed for the determination of
the shareholders of the Company entitled to receive such dividend or
distribution.

 

(d)           Adjustment of Number
of Shares. Upon each adjustment in the Warrant Price, the number of Shares
of Series Preferred purchasable hereunder shall be adjusted, to the nearest
whole share, to the product obtained by multiplying the number of Shares
purchasable immediately prior to such adjustment in the Warrant Price by a
fraction, the numerator of which shall be the Warrant Price immediately prior
to such adjustment and the denominator of which shall be the Warrant Price
immediately thereafter.

 

(e)           Antidilution Rights.
The other antidilution rights applicable to the Shares of Series Preferred
purchasable hereunder are set forth in the Company’s Amended and Restated
Certificate of Incorporation, as amended through the Date of Grant, a true and
complete copy of which is attached hereto as Exhibit B (the “Charter”).
Such antidilution rights shall not be restated, amended, modified or waived in
any manner without holder’s prior written consent if the effect of such restatement,
amendment, modification or waiver on the holder hereof would be more adverse to
the holder hereof than, and substantially dissimilar to, its effect on the
other holders of the Company’s Series Preferred. The Company shall promptly
provide the holder hereof with any restatement, amendment, modification or
waiver of the Charter promptly after the same has been made.

 

5.             Notice of
Adjustments.   Whenever the Warrant
Price or the number of Shares purchasable hereunder shall be adjusted pursuant
to Section 4 hereof, the Company shall make a certificate signed by its
chief financial officer setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which
such adjustment was calculated, and the Warrant Price and the number of Shares
purchasable hereunder after giving effect to such adjustment, and shall cause
copies of such certificate to be mailed (without regard to Section 13
hereof, by first class mail, postage prepaid) to the holder of this Warrant. In
addition, whenever the conversion price or conversion ratio of the Series
Preferred shall be adjusted, the Company shall make a certificate signed by its
chief financial officer setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which
such adjustment was calculated, and the conversion price or ratio of the Series
Preferred after giving effect to such adjustment, and shall cause copies of
such certificate to be mailed (without regard to Section 13 hereof, by first
class mail, postage prepaid) to the holder of this Warrant.

 

6.             Fractional Shares. No fractional
shares of Series Preferred will be issued in connection with any exercise
hereunder, but in lieu of such fractional shares the Company shall make a cash
payment therefor based on the fair market value of the Series Preferred on the
date of exercise as reasonably determined in good faith by the Company’s Board
of Directors.

 

 

7.             Compliance with
Act; Disposition of Warrant or Shares of Series Preferred.

 

(a)           Compliance with Act.
The holder of this Warrant, by acceptance hereof, agrees that this Warrant, and
the shares of Series Preferred to be issued upon exercise hereof and any Common
Stock issued upon conversion thereof are being acquired for investment and that
such holder will not offer, sell or otherwise dispose of this Warrant, or any
shares of Series Preferred to be issued upon exercise hereof or any Common
Stock issued upon conversion thereof except under circumstances which will not
result in a violation of the Act or any applicable state securities laws. Upon
exercise of this Warrant, unless the Shares being acquired are registered under
the Act and any applicable state securities laws or an exemption from such
registration is available, the holder hereof shall confirm in writing that the
shares of Series Preferred so purchased (and any shares of Common Stock issued
upon conversion thereof) are being acquired for investment and not with a view
toward distribution or resale in violation of the Act and shall confirm such
other matters related thereto as may be reasonably requested by the Company.
This Warrant and all shares of Series Preferred issued upon exercise of this
Warrant and all shares of Common Stock issued upon conversion thereof (unless
registered under the Act and any applicable state securities laws) shall be
stamped or imprinted with a legend in substantially the following form:

 

“THE SECURITIES EVIDENCED
HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BEEFFECTED
WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION
OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE
APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE
PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE
ISSUED, DIRECTLY OR INDIRECTLY.”

 

Said legend
shall be removed by the Company, upon the request of a holder, at such time as
the restrictions on the transfer of the applicable security shall have
terminated. In addition, in connection with the issuance of this Warrant, the
holder specifically represents to the Company by acceptance of this Warrant as
follows:

 

(1)               The holder is aware
of the Company’s business affairs and financial condition, and has acquired
information about the Company sufficient to reach an informed and knowledgeable
decision to acquire this Warrant. The holder is acquiring this Warrant for its
own account for investment purposes only and not with a view to, or for the
resale in connection with, any “distribution” thereof in violation of the Act.

 

(2)                The
holder understands that this Warrant has not been registered under the Act in
reliance upon a specific exemption therefrom, which

 

 

exemption
depends upon, among other things, the bona fide nature of the holder’s
investment intent as expressed herein.

 

(3)                The
holder further understands that this Warrant must be held indefinitely unless
subsequently registered under the Act and qualified under any applicable state
securities laws, or unless exemptions from registration and qualification are
otherwise available. The holder is aware of the provisions of Rule 144,
promulgated under the Act.

 

(4)               The holder is an
“accredited investor” as such term is defined in Rule 501 of Regulation D
promulgated under the Act.

 

(b)           Disposition of
Warrant or Shares. With respect to any offer, sale or other disposition of
this Warrant or any shares of Series Preferred acquired pursuant to the
exercise of this Warrant prior to registration of such Warrant or shares, the
holder hereof agrees to give written notice to the Company prior thereto, describing
briefly the manner thereof, together with a written opinion of such holder’s
counsel, or other evidence, if reasonably satisfactory to the Company, to the
effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect or any federal
or state securities law then in effect) of this Warrant or such shares of
Series Preferred or Common Stock and indicating whether or not under the Act
certificates for this Warrant or such shares of Series Preferred to be sold or
otherwise disposed of require any restrictive legend as to applicable
restrictions on transferability in order to ensure compliance with such law.
Upon receiving such written notice and reasonably satisfactory opinion or other
evidence, the Company, as promptly as practicable but no later than fifteen
(15) days after receipt of the written notice, shall notify such holder that
such holder may sell or otherwise dispose of this Warrant or such shares of
Series Preferred or Common Stock, all in accordance with the terms of the
notice delivered to the Company. If a determination has been made pursuant to
this Section 7(b) that the opinion of counsel for the holder or other
evidence is not reasonably satisfactory to the Company, the Company shall so
notify the holder promptly with details thereof after such determination has
been made. Notwithstanding the foregoing, this Warrant or such shares of Series
Preferred or Common Stock may, as to such federal laws, be offered, sold or otherwise
disposed of in accordance with Rule 144 or 144A under the Act, provided that
the Company shall have been furnished with such information as the Company may
reasonably request to provide a reasonable assurance that the provisions of
Rule 144 or 144A have been satisfied. Each certificate representing this
Warrant or the shares of Series Preferred thus transferred (except a transfer
pursuant to Rule 144 or 144A) shall bear a legend as to the applicable
restrictions on transferability in order to ensure compliance with such laws,
unless in the aforesaid opinion of counsel for the holder, such legend is not
required in order to ensure compliance with such laws. The Company may issue
stop transfer instructions to its transfer agent in connection with such restrictions.

 

(c)           Applicability of
Restrictions. Neither any restrictions of any legend described in this
Warrant nor the requirements of Section 7(b)
above shall apply to any

 

 

transfer of, or grant of a
security interest in, this Warrant (or the Series Preferred or Common Stock
obtainable upon exercise thereof) or any part hereof (i) to a partner of the
holder if the holder is a partnership or to a member of the holder if the
holder is a limited liability company, (ii) to a partnership of which the holder
is a partner or to a limited liability company of which the holder is a member,
or (iii) to any affiliate of the holder if the holder is a corporation; provided,
however, in any such transfer, if applicable, the transferee shall agree
in writing to be bound by the terms of this Warrant as if an original holder
hereof.

 

8.             Rights as
Shareholders; Information.  No holder
of this Warrant, as such, shall be entitled to vote or receive dividends or be
deemed the holder of Series Preferred or any other securities of the Company
which may at any time be issuable on the exercise hereof for any purpose, nor
shall anything contained herein be construed to confer upon the holder of this
Warrant, as such, any of the rights of a shareholder of the Company or any right
to vote for the election of directors or upon any matter submitted to
shareholders at any meeting thereof, or to receive notice of meetings, or to
receive dividends or subscription rights or otherwise until this Warrant shall
have been exercised and the Shares purchasable upon the exercise hereof shall
have become deliverable, as provided herein. Notwithstanding the foregoing, the
Company will transmit to the holder of this Warrant such information, documents
and reports as are generally distributed to the holders of any class or series
of the securities of the Company concurrently with the distribution thereof to
the shareholders.

 

9.             (a)           Registration Rights.
The Company grants registration rights to the holder of this Warrant for any
Common Stock of the Company obtained upon conversion of the Series Preferred,
comparable to the registration rights granted to the investors in Section 2.2
of that certain Amended and Restated Investors’ Rights Agreement dated as of
December 14, 2000, as amended (the “Registration Rights Agreement”), with the
following exceptions and clarifications:

 

(1)               The holder
acknowledges that in the event that the number of shares to be underwritten is
limited as provided in Section 2.2(a) of the Registration Rights Agreement, the
allocation of the shares to be included in the underwriting shall be as set
forth in Section 2.2(a) of the Registration Rights Agreement.

 

(2)               The holder will
have no demand registration rights as provided under Section 2.1 or 2.3 of the
Registration Rights Agreement.

 

(3)               The holder will be
subject to the same provisions regarding indemnification as contained in
Section 2.7 of the Registration Rights Agreement.

 

(4)               [NAME OF WARRANT
HOLDER], the holder of this Warrant, may assign the registration rights granted
hereunder to any permitted transferee of this Warrant or the Shares; provided
that the right to assign registration rights granted under this Warrant may be
exercised by [NAME OF WARRANT HOLDER] up to a maximum of 2 times.

 

 

(b)           Market Stand-off
Agreement. The holder of this Warrant or any shares issuable upon exercise
of this Warrant hereby agrees that during the one hundred eighty (180)-day
period following the effective date of a registration statement of the Company
filed under the Act, it shall not, to the extent requested by the Company and
the managing underwriter, sell or otherwise transfer or dispose of (other than
to donees who agree to be similarly bound) any stock of the Company held by it
at any time during such period except Common Stock included in such
registration; provided, however, that (i) such agreement shall be applicable
only to the first such registration statement of the Company which covers
Common Stock (or other securities) to be sold on its behalf to the public in an
underwritten offering; and (ii) all officers and directors of the Company and
all other persons with registration rights (whether or not pursuant to the
Registration Rights Agreement) enter into similar agreements. In order to
enforce the foregoing covenant, the Company may impose stop-transfer
instructions with respect to the Warrant and shares issuable upon exercise of
the Warrant of the holder (and shares or securities of every other person
subject to the foregoing restriction) until the end of such period.

 

10.           Additional Rights.

 

10.1           Acquisition
Transactions. The Company shall provide the holder of this Warrant with at
least ten (10) days’ written notice prior to closing thereof of the terms and
conditions of any of the following transactions (to the extent the Company has
notice thereof): (i) the sale, lease, exchange, conveyance or other disposition
of all or substantially all of the Company’s property or business, or (ii) its
merger into or consolidation with any other corporation (other than a
wholly-owned subsidiary of the Company), or any transaction (including a merger
or other reorganization) or series of related transactions, in which more than
50% of the voting power of the Company is disposed of.

 

10.2          Right
to Convert Warrant into Stock; Net Issuance.

 

(a)           Right to Convert.  In addition to and without limiting the
rights of the holder under the terms of this Warrant, the holder shall have the
right to convert this Warrant or any portion thereof (the “Conversion Right”)
into shares of Series Preferred (or Common Stock if the Series Preferred has
been automatically converted into Common Stock) as provided in this Section
10.2 at any time or from time to time during the term of this Warrant. Upon
exercise of the Conversion Right with respect to a particular number of shares
subject to this Warrant (the “Converted Warrant Shares”), the Company shall
deliver to the holder (without payment by the holder of any exercise price or
any cash or other consideration) that number of shares of fully paid and
nonassessable Series Preferred (or Common Stock if the Series Preferred has
been automatically converted into Common Stock) as is determined according to
the following formula:

 

	
  X=

  	
  B-A

  	
   

  	
   

  
	
   

  	
  Y

  	
   

  	
   

  

 

 

	
  Where: X =

  	
   

  	
  the number
  of shares of Series Preferred (or Common Stock if the Series Preferred has
  been automatically converted to Common Stock) that shall be issued to holder

  
	
   

  	
   

  	
   

  
	
  Y =

  	
   

  	
  the fair
  market value of one share of Series Preferred (or Common Stock if the Series
  Preferred has been automatically converted to Common Stock)

  
	
   

  	
   

  	
   

  
	
  A =

  	
   

  	
  the
  aggregate Warrant Price of the specified number of Converted Warrant Shares
  immediately prior to the exercise of the Conversion Right (i.e., the number of Converted Warrant
  Shares multiplied by the Warrant Price)

  
	
   

  	
   

  	
   

  
	
  B =

  	
   

  	
  the
  aggregate fair market value of the specified number of Converted Warrant
  Shares (i.e., the number of
  Converted Warrant Shares multiplied by the fair market value of one
  Converted Warrant Share)

  

 

No fractional
shares shall be issuable upon exercise of the Conversion Right, and, if the
number of shares to be issued determined in accordance with the foregoing
formula is other than a whole number, the Company shall pay to the holder an
amount in cash equal to the fair market value of the resulting fractional share
on the Conversion Date (as hereinafter defined). For purposes of Section 10 of
this Warrant, shares issued pursuant to the Conversion Right shall be treated
as if they were issued upon the exercise of this Warrant.

 

(b)           Method of Exercise.  The Conversion Right may be exercised by the
holder by the surrender of this Warrant at the principal office of the Company
together with a written statement (which may be in the form of Exhibit A-1
or Exhibit A-2 hereto) specifying that the holder thereby intends to
exercise the Conversion Right and indicating the number of shares subject to
this Warrant which are being surrendered (referred to in Section 10.2(a)
hereof as the Converted Warrant Shares) in exercise of the Conversion Right.
Such conversion shall be effective upon receipt by the Company of this Warrant
together with the aforesaid written statement, or on such later date as is
specified therein (the “Conversion Date”), and, at the election of the holder
hereof, may be made contingent upon the closing of the sale of the Company’s
Common Stock to the public in a public offering pursuant to a Registration
Statement under the Act (a “Public Offering”). Certificates for the shares
issuable upon exercise of the Conversion Right and, if applicable, a new
warrant evidencing the balance of the shares remaining subject to this Warrant,
shall be issued as of the Conversion Date and shall be delivered to the holder
within thirty (30) days following the Conversion Date.

 

(c)           Determination of
Fair Market Value.  For purposes of this
Section 10.2, “fair market value” of a share of Series Preferred (or
Common Stock if the Series Preferred has been automatically converted into
Common Stock) as of a

 

 

particular
date (the “Determination Date”) shall mean:

 

(i)            If the Conversion Right
is exercised in connection with and contingent upon a Public Offering, and if
the Company’s Registration Statement relating to such Public Offering has been
declared effective by the Securities and Exchange Commission, then the initial
“Price to Public” specified in the final prospectus with respect to such
offering.

 

(ii)             If
the Conversion Right is not exercised in connection with and contingent upon a
Public Offering, then as follows:

 

(A)            If traded on a
securities exchange, the fair market value of the Common Stock shall be deemed
to be the average of the closing prices of the Common Stock on such exchange
over the five trading days immediately prior to the Determination Date, and the
fair market value of the Series Preferred shall be deemed to be such fair
market value of the Common Stock multiplied by the number of shares of Common
Stock into which each share of Series Preferred is then convertible;

 

(B)            If traded on the
Nasdaq Stock Market or other over-the-counter system, the fair market value of
the Common Stock shall be deemed to be the average of the closing prices of the
Common Stock over the five trading days immediately prior to the Determination
Date, and the fair market value of the Series Preferred shall be deemed to be
such fair market value of the Common Stock multiplied by the number of shares
of Common Stock into which each share of Series Preferred is then convertible;
and

 

(C)            If there is no public
market for the Common Stock, then fair market value shall be as reasonably
determined in good faith by the Board of Directors of the Company; provided,
however, that in the event a holder of this Warrant disputes the determination
of the Board of Directors, a nationally recognized investment banking or
accounting firm shall be retained to make a final and binding determination,
with half of the expenses borne by the Company, and half of the expenses borne
by the holder of this Warrant.

 

10.3 Exercise
Prior to Expiration.  To the extent
this Warrant is not previously exercised as to all of the Shares subject
hereto, and if the fair market value of one share of the Series Preferred is
greater than the Warrant Price then in effect, this Warrant shall be deemed
automatically exercised pursuant to Section 10.2 above (even if not
surrendered) immediately before its expiration. For purposes of such automatic
exercise, the fair market value of one share of the Series Preferred upon such
expiration shall be determined pursuant to Section 10.2(c). To the
extent this Warrant or any portion thereof is deemed automatically exercised
pursuant to this Section 10.3, the Company agrees to promptly
notify the holder hereof of the number of Shares, if any, the holder hereof is
to receive by reason of such automatic exercise.

 

 

11.           Representations and
Warranties.  The Company represents
and warrants to the holder of this Warrant as follows:

 

(a)           This Warrant has been
duly authorized and executed by the Company and is a valid and binding
obligation of the Company enforceable in accordance with its terms, subject to laws
of general application relating to bankruptcy, insolvency and the relief of
debtors and the rules of law or principles at equity governing specific
performance, injunctive relief and other equitable remedies;

 

(b)           The Shares have been
duly authorized and reserved for issuance by the Company and, when issued in
accordance with the terms hereof, will be validly issued, fully paid and
nonassessable;

 

(c)           The rights,
preferences, privileges and restrictions granted to or imposed upon the Series
Preferred and the holders thereof are as set forth in the Charter, and on the
Date of Grant, each share of the Series Preferred represented by this Warrant
is convertible into one share of Common Stock;

 

(d)           The shares of Common
Stock issuable upon conversion of the Shares have been duly authorized and
reserved for issuance by the Company and, when issued in accordance with the
terms of the Charter will be validly issued, fully paid and nonassessable;

 

(e)           The execution and
delivery of this Warrant are not, and the issuance of the Shares upon exercise
of this Warrant in accordance with the terms hereof will not be, inconsistent
with the Company’s Charter or by-laws, do not and will not contravene any law,
governmental rule or regulation, judgment or order applicable to the Company,
and do not and will not conflict with or contravene any provision of, or
constitute a default under, any indenture, mortgage, contract or other
instrument of which the Company is a party or by which it is bound or require
the consent or approval of, the giving of notice to, the registration or filing
with or the taking of any action in respect of or by, any Federal, state or
local government authority or agency or other person, except for the filing of
notices pursuant to federal and state securities laws, which filings will be
effected by the time required thereby;

 

(f)            There are no actions,
suits, audits, investigations or proceedings pending or, to the knowledge of
the Company, threatened against the Company in any court or before any governmental
commission, board or authority which, if adversely determined, will have a
material adverse effect on the ability of the Company to perform its
obligations under this Warrant; and

 

(g) The number
of shares of Common Stock of the Company outstanding on the date hereof, on a
fully diluted basis (assuming the conversion of all outstanding convertible
securities and the exercise of all outstanding options and warrants), does not
exceed 39,240,000 shares.

 

 

12.           Modification and
Waiver.  This Warrant and any
provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of the same
is sought.

 

13.           Notices.  Except as otherwise set forth in this
Warrant, any notice, request, communication or other document required or
permitted to be given or delivered to the holder hereof or the Company shall be
delivered, or shall be sent by certified or registered mail, postage prepaid,
to each such holder at its address as shown on the books of the Company or to
the Company at the address indicated therefor on the signature page of this
Warrant.

 

14.           Binding Effect on
Successors.  This Warrant shall be
binding upon any corporation succeeding the Company by merger, consolidation or
acquisition of all or substantially all of the Company’s assets, and all of the
obligations of the Company relating to the Series Preferred issuable upon the
exercise or conversion of this Warrant shall survive the exercise, conversion
and termination of this Warrant and all of the covenants and agreements of the
Company shall inure to the benefit of the successors and assigns of the holder
hereof.

 

15.           Lost Warrants or
Stock Certificates.  The Company
covenants to the holder hereof that, upon receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant or any stock certificate and, in the case of any such loss, theft
or destruction, upon receipt of an indemnity reasonably satisfactory to the
Company, or in the case of any such mutilation upon surrender and cancellation
of such Warrant or stock certificate, the Company will make and deliver a new
Warrant or stock certificate, of like tenor, in lieu of the lost, stolen,
destroyed or mutilated Warrant or stock certificate.

 

16.           Descriptive
Headings.  The descriptive headings
of the several paragraphs of thisWarrant are inserted for convenience only and
do not constitute a part of this Warrant. The language in this Warrant shall be
construed as to its fair meaning without regard to which party drafted this
Warrant.

 

17.           Governing Law.  This Warrant shall be construed and enforced
in accordance with, and the rights of the parties shall be governed by, the
laws of the State of Delaware.

 

18.           Survival of
Representations, Warranties and Agreements. 
All representations and warranties of the Company and the holder hereof
contained herein shall survive the Date of Grant, the exercise or conversion of
this Warrant (or any part hereof) or the termination or expiration of rights
hereunder. All agreements of the Company and the holder hereof contained herein
shall survive indefinitely until, by their respective terms, they are no longer
operative.

 

19.           Remedies.  In case any one or more of the covenants and
agreements contained in this Warrant shall have been breached, the holders
hereof (in the case of a

 

 

breach by the Company), or the
Company (in the case of a breach by a holder), may proceed to protect and
enforce their or its rights either by suit in equity and/or by action at law,
including, but not limited to, an action for damages as a result of any such
breach and/or an action for specific performance of any such covenant or
agreement contained in this Warrant.

 

20.           No Impairment of
Rights.  The Company will not, by
amendment of its Charter or through any other means, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the
taking of all such action as may be necessary or appropriate in order to
protect the rights of the holder of this Warrant against impairment.

 

21.           Severability.  The invalidity or unenforceability of any
provision of this Warrant in any jurisdiction shall not affect the validity or
enforceability of such provision in any other jurisdiction, or affect any other
provision of this Warrant, which shall remain in full force and effect.

 

22.           Recovery of
Litigation Costs.  If any legal
action or other proceeding is brought for the enforcement of this Warrant, or
because of an alleged dispute, breach, default, or misrepresentation in
connection with any of the provisions of this Warrant, the successful or
prevailing party or parties shall be entitled to recover reasonable attorneys’
fees and other costs incurred in that action or proceeding, in addition to any
other relief to which it or they may be entitled.

 

23.           Entire Agreement;
Modification.  This Warrant
constitutes the entire agreement between the parties pertaining to the subject
matter contained in it and supersedes all prior and contemporaneous agreements,
representations, and undertakings of the parties, whether oral or written, with
respect to such subject matter.

 

The Company
has caused this Warrant to be duly executed and delivered as of the Date of
Grant specified above.

 

 

	
   

  	
  RIGHTNOW
  TECHNOLOGIES, INC.

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ SUSAN J.
  CARSTENSEN

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
  CFO

  	
   

  
	
   

  	
   

  
	
   

  	
  Address:

  	
  40
  Enterprise Boulevard

  
	
   

  	
   

  	
  P.O. Box
  9300

  
	
   

  	
  Bozeman, MT
  59718-9300

  
							

 

 

EXHIBIT A-1

 

NOTICE OF EXERCISE

 

To: RIGHTNOW TECHNOLOGIES, INC.
(the “Company”)

 

1.               The undersigned
hereby:

 

o                               elects
to
purchase              
shares of Series B Preferred Stock of the Company pursuant to the terms of the
attached Warrant, and tenders herewith payment of the purchase price of such
shares in full, or

 

o                               elects to exercise its net issuance rights pursuant to Section
10.2 of the attached Warrant with respect
to              
shares of Series B Preferred Stock.

 

2.               Please issue a
certificate or certificates
representing                         
shares in the name of the undersigned or in such other name or names as are
specified below:

 

	
   

  	
   

  	
   

  
	
   

  	
  (Name)

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  (Address)

  	
   

  

 

 

3.               The undersigned
represents that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and that the undersigned has no present
intention of distributing or reselling such shares, all except as in compliance
with applicable securities laws.

 

 

	
   

  	
   

  
	
   

  	
  (Signature)

  
	
   

  
	
   

  
	
   

  	
   

  
	
  (Date)

  	
   

  
			

 

 

EXHIBIT A-2

 

NOTICE OF EXERCISE

 

To: RIGHTNOW TECHNOLOGIES, INC.
(the “Company”)

 

1.             Contingent upon and
effective immediately prior to the closing (the “Closing”) of the Company’s
public offering contemplated by the Registration Statement on Form
S               ,
filed                              ,
20   , the undersigned hereby:

 

o            elects to
purchase                              
shares of Series B Preferred Stock of the Company (or such lesser number of
shares as may be sold on behalf of the undersigned at the Closing) pursuant to
the terms of the attached Warrant, or

 

o            elects to exercise
its net issuance rights pursuant to Section 10.2 of the attached Warrant
with respect
to                              
shares of Series B Preferred Stock.

 

2.             Please deliver to the
custodian for the selling shareholders a stock certificate representing
such                              
shares.

 

3.             The undersigned has
instructed the custodian for the selling shareholders to deliver to the Company
$                   or,
if less, the net proceeds due the undersigned from the sale of shares in the
aforesaid public offering. If such net proceeds are less than the purchase
price for such shares, the undersigned agrees to deliver the difference to the
Company prior to the Closing.

 

 

	
   

  	
   

  	
   

  
	
   

  	
  (Signature)

  	
   

  
	
   

  
	
   

  
	
   

  	
   

  
	
  (Date)

  	
   

  
				

 

 

SCHEDULE OF MATERIAL DIFFERENCES

TO EXHIBIT 4.3

 

The warrants are identical in
all material respects with the exception of the identity of the warrant holder,
the date of grant and the number of shares.*

 

	
  Name of Warrant Holder

  	
   

  	
  Date of Grant

  	
   

  	
  Number of Shares

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  PRIORITY CAPITAL

  	
   

  	
  May 1, 2001

  	
   

  	
  12,500

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  GATX VENTURES, INC.

  	
   

  	
  May 1, 2001

  	
   

  	
  58,333

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  PRIORITY CAPITAL

  	
   

  	
  December 7, 2001

  	
   

  	
  40,000

  	
   

  

 

 

*  Share numbers
and exercise prices in the warrants do not reflect the two-for-three reverse
stock split of RightNow Technologies, Inc.’s capital stock that was effected on
July 14, 2004.Exhibit 4.4

 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE
SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION
THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL THAT SUCH
REGISTRATION IS NOT REQUIRED.

 

WARRANT
TO PURCHASE STOCK

 

	
  Corporation:

  	
  RightNow Technologies, Inc., a
  Delaware corporation

  
	
  Number of Shares:

  	
  [NUMBER OF SHARES]

  
	
  Class of Stock:

  	
  Series B Preferred

  
	
  Initial Exercise Price:

  	
  $3.00 per share

  
	
  Issue Date:

  	
  [ISSUE DATE]

  
	
  Expiration Date:

  	
  [EXPIRATION DATE] (Subject to
  Article 4.1)

  

 

THIS WARRANT CERTIFIES THAT, in
consideration of the payment of $1.00 and for other good and valuable
consideration, COMERICA BANK or its assignee (“Holder”) is entitled to
purchase the number of fully paid and nonassessable shares of the class of
securities (the “Shares”) of the corporation (the “Company”) at
the initial exercise price per Share (the “Warrant Price”‘) all as set
forth above and as adjusted pursuant to Article 2 of this warrant, subject to
the provisions and upon the terms and conditions set forth in this warrant.

 

ARTICLE 1. EXERCISE

 

1.1             Method
of Exercise.  Holder may exercise
this warrant by delivering this warrant and a duly executed Notice of Exercise
in substantially the form attached as Appendix 1 to the principal office of the
Company. Unless Holder is exercising the conversion right set forth in Section
1.2, Holder shall also deliver to the Company a check for the aggregate Warrant
Price for the Shares being purchased.

 

1.2             Conversion
Right.  In lieu of exercising this
warrant as specified in Section 1.1, Holder may from time to time convert this
warrant, in whole or in part, into a number of Shares determined by dividing
(a) the aggregate fair market value of the Shares or other securities otherwise
issuable upon exercise of this warrant minus the aggregate Warrant Price of
such Shares by (b) the fair market value of one Share. The fair market value of
the Shares shall be determined pursuant to Section 1.3.

 

1.3             Fair
Market Value. If the Shares are traded regularly in a public market, the
fair market value of the Shares shall be the closing price of the Shares (or
the closing price of the Company’s stock into which the Shares are convertible)
reported for the business day immediately before Holder delivers its Notice of
Exercise to the Company. If the Shares are not regularly traded in a public
market, the Board of Directors of the Company shall determine fair market value
in its reasonable good faith judgment.

 

1.4             Delivery
of Certificate and New Warrant. 
Promptly after Holder exercises or converts this warrant, the Company
shall deliver to Holder certificates for the Shares acquired and, if this
warrant has not been fully exercised or converted and has not expired, a new
warrant representing the Shares not so acquired.

 

1.5             Replacement
of Warrants.  On receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this warrant and, in the case of loss, theft or destruction, on
delivery of an indemnity agreement reasonably satisfactory in form and amount
to the Company or, in the case of mutilation, on surrender and cancellation of
this warrant, the Company at its expense shall execute and deliver, in lieu of
this warrant, a new warrant of like tenor.

 

1.6             Repurchase
on Sale, Merger, or Consolidation of the Company.

 

1.6.1        “Acquisition.”  For the purpose of this warrant, “Acquisition”
means any sale, license, or other disposition of all or substantially all of
the assets (including intellectual property) of the Company, or any
reorganization, consolidation, or merger of the Company where the holders of
the Company’s securities before the transaction beneficially own less than 50%
of the outstanding voting securities of the surviving entity after the
transaction.

 

1.6.2        Assumption
of Warrant.  If upon the closing of
any Acquisition the successor entity assumes the obligations of this warrant,
then this warrant shall be exercisable for the same securities, cash, and
property as would be payable for the Shares issuable upon exercise of the
unexercised portion of this warrant as if such Shares were outstanding on the
record date for the Acquisition and subsequent closing. The Warrant Price shall
be adjusted accordingly. The Company shall use reasonable efforts to cause the
surviving corporation to assume the obligations of this warrant.

 

1

 

1.6.3        Nonassumption.  If upon the closing of any Acquisition the
successor entity does not assume the obligations of this warrant and Holder has
not otherwise exercised this warrant in full, then this warrant shall be
automatically converted pursuant to Section 1.2 and thereafter Holder shall
participate in the Acquisition on the same terms as other holders of the same
class o f securities of the Company.

 

ARTICLE 2. ADJUSTMENTS TO THE
SHARES.

 

2.1             Stock
Dividends, Splits, Etc.  If the
Company at any time shall pay a dividend payable in, or make any other
distribution of, the Company’s stock to the holders of outstanding shares of
the Company’s Series B Preferred Stock (or common stock only if the Series B
Preferred Stock has been converted into common stock while this warrant is
outstanding), then, upon exercise of this warrant, Holder shall be entitled to
receive, in addition to the number of shares of Series B Preferred Stock (or
common stock only if the Series B Preferred Stock has been converted into
common stock while this warrant is outstanding) receivable thereupon, and
without payment of any additional consideration therefor, the amount of the
Company’s capital stock which would have been issuable to Holder if Holder had
exercised this warrant immediately prior to the date on which holders of Series
B Preferred Stock (or common stock only if the Preferred Stock has been
converted into common stock while this warrant is outstanding) received such
dividend or distribution of the Company’s capital stock.

 

2.2             Reclassification,
Exchange or Substitution. Upon any reclassification, exchange,
substitution, or other event that results in a change of the number and/or
class of the securities issuable upon exercise or conversion of this warrant,
Holder shall be entitled to receive, upon exercise or conversion of this
warrant, the number and kind of securities and property that Holder would have
received for the Shares if this warrant had been exercised immediately before
such reclassification, exchange, substitution, or other event. Such an event
shall include any automatic or other conversion of the outstanding or issuable
securities of the Company of the same class or series as the Shares to common
stock pursuant to the terms of the Company’s Certificate of Incorporation. The
Company or its successor shall promptly issue to Holder a new warrant for such
new securities or other property. The new warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Article 2 including, without limitation, adjustments to
the Warrant Price and to the number of securities or property issuable upon
exercise of the new warrant. The provisions of this Section 2.2 shall similarly
apply to successive reclassifications, exchanges, substitutions, or other
events.

 

2.3             Adjustments
for Combinations, Etc.  If the
outstanding Shares are combined or consolidated, by reclassification or
otherwise, into a lesser number of shares, the Warrant Price shall be proportionately
increased.

 

2.4             No
Impairment.  The Company shall not,
by amendment of its Certificate of Incorporation or through a reorganization,
transfer of assets, consolidation, merger, dissolution, issue, or sale of
securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed under this
warrant by the Company, but shall at all times in good faith assist in carrying
out all the provisions of this Article 2 and in taking all such action as may
be necessary or appropriate to protect Holder’s rights under this Article
against impairment.

 

2.5             Certificate
as to Adjustments.  Upon each
adjustment of the Warrant Price, the Company at its expense shall promptly
compute such adjustment, and furnish Holder with a certificate of its Chief
Financial Officer setting forth such adjustment and the facts upon which such
adjustment is based. The Company shall, upon written request, furnish Holder a
certificate setting forth the Warrant Price in effect upon the date thereof and
the series of adjustments leading to such Warrant Price.

 

ARTICLE 3. REPRESENTATIONS AND COVENANTS OF THE
COMPANY.

 

3.1             Representations
and Warranties.  The Company hereby
represents and warrants to the Holder as follows:

 

(a)           The
initial Warrant Price referenced on the first page of this warrant is the price
per share that the Company’s Series B Preferred Stock was sold to outside
investors.

 

(b)           All
Shares which may be issued upon the exercise of the purchase right represented
by this warrant, and all securities, if any, issuable upon conversion of the
Shares, shall, upon issuance, be duly authorized, validly issued, fully paid
and nonassessable, and free of any liens and encumbrances except for
restrictions on transfer provided for herein or under applicable federal and
state securities laws.

 

(c)           The
Company’s capitalization table attached to this warrant is true and complete as
of the Issue Date.

 

2

 

3.2             Notice
of Certain Events.  If the Company
proposes at any time (a) to declare any dividend or distribution upon its
common stock, whether in cash, property, stock, or other securities and whether
or not a regular cash dividend; (b) to offer for subscription pro rata to the
holders of any class or series of its stock any additional shares of stock of
any class or series or other rights; (c) to effect any reclassification or
recapitalization of common stock; or (d) to merge or consolidate with or into
any other corporation, or sell, lease, license, or convey all or substantially
all of its assets, or to liquidate, dissolve or wind up, then, in connection
with each such event, the Company shall give Holder (1) at least 20 days prior
written notice of the date on which a record will be taken for such dividend,
distribution, or subscription rights (and specifying the date on which the
holders of common stock will be entitled thereto) or for determining rights to
vote, if any, in respect of the matters referred to in (a) and (b) above; and
(2) in the case of the matters referred to in (c) and (d) above at least 20
days prior written notice of the date when the same will take place (and
specifying the date on which the holders of common stock will be entitled to
exchange their common stock for securities or other property deliverable upon
the occurrence of such event).

 

3.3             Information
Rights. So long as the Holder holds this warrant and/or any of the
Shares, unless at least one class of the Company’s stock is publicly traded,
the Company shall deliver to the Holder (a) promptly after mailing, copies of
all communiques to the shareholders of the Company, (b) within one hundred
twenty (120) days after the end of each fiscal year of the Company, the annual
audited financial statements of the Company certified by independent
public accountants of recognized standing and (c) within forty-five (45) days
after the end of each of the first three quarters of each fiscal year, the
Company’s quarterly, unaudited financial statements.

 

ARTICLE 4. MISCELLANEOUS.

 

4.1             Term  This warrant is exercisable in whole or in
part, at any time and from time to time on or before the Expiration Date set
forth above; provided, however, that if the Company completes its initial
public offering within the three-year period immediately prior to the
Expiration Date, the Expiration Date shall automatically be extended until the
third anniversary of the effective date of the Company’s initial public
offering. If this warrant has not been exercised prior to the Expiration Date,
this warrant shall be deemed to have been automatically exercised on the
Expiration Date by “cashless” conversion pursuant to Section 1.2.

 

4.2              Legends.  This warrant and the Shares (and the
securities issuable, directly or indirectly, upon conversion of the Shares, if
any) shall be imprinted with a legend in substantially the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE
TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR
PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE
CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.

 

4.3             Compliance
with Securities Laws on Transfer. 
This warrant and the Shares issuable upon exercise of this warrant (and
the securities issuable, directly or indirectly, upon conversion of the Shares,
if any) may not be transferred or assigned in whole or in part without
compliance with applicable federal and state securities laws by the transferor
and the transferee (including, without limitation, the delivery of investment
representation letters and legal opinions reasonably satisfactory to the
Company). The Company shall not require Holder to provide an opinion of counsel
if the transfer is to an affiliate of Holder or if there is no material
question as to the availability of current information as referenced in Rule
144(c), Holder represents that it has complied with Rule 144(d) and (e) in
reasonable detail, the selling broker represents that it has complied with Rule
144(f), and the Company is provided with a copy of Holder’s notice of proposed
sale.

 

4.4             Transfer
Procedure.  Subject to the provisions
of Section 4.3, Holder may transfer all or part of this warrant or the Shares
issuable upon exercise of this warrant (or the securities issuable, directly or
indirectly, upon conversion of the Shares, if any) by giving the Company notice
of the portion of the warrant being transferred setting forth the name, address
and taxpayer identification number o f the transferee and surrendering this
warrant to the Company for reissuance to the transferee(s) (and Holder, if
applicable); provided, however, that Holder may transfer all or
part of this warrant to its affiliates, including, without limitation, Holder’s
parent company, at any time without notice to the Company, and such affiliate
shall then be entitled to all the rights of Holder under this warrant and any
related agreements, and the Company shall cooperate fully in ensuring that any
stock issued upon exercise of this warrant is issued in the name of the
affiliate that exercises the warrant. The terms and conditions of this warrant
shall inure to the benefit of, and be binding upon, the Company and the holders
hereof and their respective permitted successors and assigns. Unless the
Company is filing financial information with the SEC pursuant to the Securities
Exchange Act of 1934, the Company shall have the right to refuse to transfer
any portion of this warrant to any person (including any of its affiliates) who
directly competes with the Company.

 

4.5             Rights
as Stockholders.  No Holder of this
warrant, as such, shall be entitled to vote or receive dividends or be deemed
the holder of Shares or any other securities of the Company which may at any
time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the

 

3

 

Holder of this warrant, as such, any of the rights of a stockholder of
the Company or any right to vote for the election of directors or upon any
matter submitted to stockholders at any meeting thereof, or to receive notice
of meetings, or to receive dividends or subscription rights or otherwise until
this warrant shall have been exercised and the Shares purchasable upon the
exercise hereof shall have become deliverable, as provided herein. Notwithstanding the foregoing, the Company will
transmit to the Holder of this warrant such information as set forth in Section
3.3 of this warrant.

 

4.6             Market
Stand-off Agreement.  The Holder of
this warrant or any shares issuable upon exercise of this warrant hereby agrees
that during the one hundred eighty (180)-day period following the effective
date of a registration statement of the Company filed under the Securities Act
of 1933, as amended, it shall not, to the extent requested by the Company and
the managing underwriter, sell or otherwise transfer or dispose of (other than
to donees who agree to be similarly bound) any stock of the Company held by it
at any time during such period except common stock included in such
registration; provided, however, that (i) such agreement shall be
applicable only to the first such registration statement of the Company which
covers common stock (or other securities) to be sold on its behalf to the
public in an underwritten offering; and (ii) all officers and directors of the
Company enter into similar agreements. In order to enforce the foregoing
covenant, the Company may impose stop-transfer instructions with respect to the
warrant and shares issuable upon exercise of the warrant of the Holder (and
shares or securities of every other person subject to the foregoing
restriction) until the end of such period.

 

4.7             Notices.
All notices and other communications from the Company to the Holder, or vice
versa, shall be deemed delivered and effective when given personally or mailed
by first-class registered or certified mail, postage prepaid, at such address
as may have been furnished to the Company or the Holder, as the case may be, in
writing by the Company or such Holder from time to time. All notices to the
Holder shall be addressed as follows:

 

Comerica Bank

Attn: Controllers Department

P.O. Box 92991

Los Angeles, CA 90009-2991

 

with a copy to:

 

Comerica
Bank

Attn:
Warrant Administrator

Special
Markets Division

P.O. Box
7279

San
Francisco, CA 94120-7279

 

4.8             Waiver.  This warrant and any term hereof may be
changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of such change, waiver, discharge
or termination is sought.

 

4.9             Attorneys’
Fees.  In the event of any dispute
between the parties concerning the terms and provisions of this warrant, the
party prevailing in such dispute shall be entitled to collect from the other
party all costs incurred in such dispute, including reasonable attorneys’ fees.

 

4.10           Governing
Law.  This warrant shall be governed
by and construed in accordance with the laws of the State of Delaware, without giving
effect to its principles regarding conflicts of law.

 

	
   

  	
  RIGHTNOW TECHNOLOGIES, INC.

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ SUSAN J. CARSTENSEN

  
	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
  Susan J.
  Carstensen

  
	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
  CFO

  
						

 

 

Authorized signatories under Corporate Resolutions to
Borrow or an authorized signer(s) under a resolution covering warrants must
sign the warrant.

 

4

 

APPENDIX
I

 

NOTICE OF
EXERCISE

 

1.             The
undersigned hereby elects to purchase
                          shares
of the                           
stock of RIGHTNOW TECHNOLOGIES, INC. pursuant to the terms of the attached
warrant, and tenders herewith payment of the purchase price of such shares in
full.

 

1.             The
undersigned hereby elects to convert the attached warrant into shares in the
manner specified in the warrant. This conversion is exercised with respect to
                                    
of the shares covered by the warrant.

 

[Strike paragraph
that does not apply.]

 

2.             Please
issue a certificate or certificates representing said shares in the name of the
undersigned or in such other name as is specified below:

 

Comerica Bank

Attn: Controllers Department

P.O. Box 92991

Los Angeles, CA 90009

Or Registered Assignee

 

3.             The
undersigned represents it is acquiring the shares solely for its own account
and not as a nominee for any other party and not with a view toward the resale
or distribution thereof except in compliance with applicable securities laws.

 

COMERICA BANK or Registered Assignee

 

 

	
   

  	
   

  
	
  (Signature)

  
	
   

  
	
   

  	
   

  
	
  (Date)

  

 

5

 

SCHEDULE
OF MATERIAL DIFFERENCES

TO EXHIBIT 4.4

 

The warrants are identical in all material respects
with the exception of the number of shares, the issue date and the expiration
date.*

 

	
  Number of Shares

  	
   

  	
  Issue Date

  	
   

  	
  Expiration Date

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  20,000

  	
   

  	
  December 7, 2001

  	
   

  	
  December 7, 2006

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  20,000

  	
   

  	
  January 24, 2003

  	
   

  	
  January 24, 2008

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  22,000

  	
   

  	
  February 24, 2004

  	
   

  	
  February 24, 2009

  	
   

  

 

*  Share numbers
and exercise prices in the warrants do not reflect the two-for-three reverse
stock split of RightNow Technologies, Inc.’s capital stock that was effected on
July 14, 2004.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]